Laurion Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.48M | Buy |
+17,812
| New | +$2.49M | 0.11% | 190 |
|
|
2025
Q4 | – | Sell |
-8,900
| Closed | -$988K | – | 353 |
|
|
2025
Q3 | $988K | Buy |
+8,900
| New | +$1.01M | 0.02% | 182 |
|
|
2024
Q3 | – | Sell |
-5,421
| Closed | -$372K | – | 418 |
|
|
2024
Q2 | $372K | Buy |
+5,421
| New | +$362K | ﹤0.01% | 389 |
|
|
2024
Q1 | – | Sell |
-108,096
| Closed | -$8.76M | – | 558 |
|
|
2023
Q4 | $8.76M | Buy |
+108,096
| New | +$8.41M | 0.07% | 195 |
|
|
2023
Q2 | – | Sell |
-5,973
| Closed | -$496K | – | 637 |
|
|
2023
Q1 | $496K | Buy |
+5,973
| New | +$495K | ﹤0.01% | 344 |
|
|
2022
Q2 | – | Sell |
-8,380
| Closed | -$498K | – | 563 |
|
|
2022
Q1 | $498K | Buy |
8,380
+3,580
| +75% | +$229K | 0.01% | 313 |
|
|
2021
Q4 | $348K | Sell |
4,800
-10,200
| -68% | -$703K | ﹤0.01% | 448 |
|
|
2021
Q3 | $1.05M | Buy |
+15,000
| New | +$1.05M | ﹤0.01% | 508 |
|
|
2021
Q1 | – | Sell |
-18,442
| Closed | -$1.07M | – | 803 |
|
|
2020
Q4 | $1.07M | Buy |
+18,442
| New | +$1.11M | 0.01% | 401 |
|
|
2020
Q3 | – | Sell |
-3,324
| Closed | -$256K | – | 949 |
|
|
2020
Q2 | $256K | Buy |
+3,324
| New | +$255K | ﹤0.01% | 749 |
|
|
2020
Q1 | – | Sell |
-21,246
| Closed | -$1.38M | – | 882 |
|
|
2019
Q4 | $1.38M | Sell |
21,246
-171,949
| -89% | -$11.2M | 0.01% | 520 |
|
|
2019
Q3 | $12.2M | Buy |
193,195
+192,395
| +24,049% | +$12.6M | 0.09% | 206 |
|
|
2019
Q2 | $54K | Buy |
+800
| New | +$52.6K | ﹤0.01% | 849 |
|
|
2019
Q1 | – | Sell |
-101,572
| Closed | -$6.35M | – | 1008 |
|
|
2018
Q4 | $6.35M | Buy |
+101,572
| New | +$7.1M | 0.11% | 230 |
|
|
2018
Q3 | – | Sell |
-638
| Closed | -$48.2K | – | 1311 |
|
|
2018
Q2 | $45K | Sell |
638
-9,240
| -94% | -$652K | ﹤0.01% | 1273 |
|
|
2018
Q1 | $745K | Buy |
+9,878
| New | +$785K | 0.01% | 909 |
|
|
2017
Q3 | – | Sell |
-14,300
| Closed | -$1.09M | – | 1682 |
|
|
2017
Q2 | $1.01M | Sell |
14,300
-58,073
| -80% | -$3.86M | 0.01% | 1023 |
|
|
2017
Q1 | $4.92M | Buy |
72,373
+59,073
| +444% | +$4.15M | 0.04% | 418 |
|
|
2016
Q4 | $952K | Buy |
13,300
+11,200
| +533% | +$832K | 0.01% | 729 |
|
|
2016
Q3 | $166K | Sell |
2,100
-9,500
| -82% | -$772K | ﹤0.01% | 834 |
|
|
2016
Q2 | $968K | Sell |
11,600
-191,909
| -94% | -$17M | 0.02% | 487 |
|
|
2016
Q1 | $18.7M | Buy |
203,509
+131,309
| +182% | +$11.8M | 0.3% | 88 |
|
|
2015
Q4 | $7.31M | Buy |
+72,200
| New | +$7.51M | 0.07% | 258 |
|
Other funds holding GILD
VCM
VPM
Laurion Capital Management's GILD Position: Q1 2026 in Review
Laurion Capital Management opened a new position in Gilead Sciences (GILD) in Q1 2026: 17,812 shares worth $2.48M. The stake represents 0.11% of the portfolio and ranks #190 among its holdings. This is a return to the name: Laurion Capital Management previously reported a position in GILD as recently as Q3 2025.
Laurion Capital Management first reported a position in GILD in Q4 2015 and has held it in 23 quarters since. The position peaked at $18.7M in Q1 2016. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Laurion Capital Management held 17,812 shares of Gilead Sciences worth $2.48M as of Q1 2026.
- Gilead Sciences was a new Laurion Capital Management position in Q1 2026.
- Gilead Sciences made up 0.11% of Laurion Capital Management's portfolio in Q1 2026, its #190 holding.
- Laurion Capital Management first reported a position in Gilead Sciences in Q4 2015 and has held it in 23 quarters since.
- Laurion Capital Management's Gilead Sciences position peaked at $18.7M in Q1 2016.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Laurion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.